LSD Dose-Response Study: A Double-Blind, Placebo-Controlled Crossover Trial
2025-02-12
This study employed a double-blind, placebo-controlled, crossover design with six experimental sessions to investigate the effects of varying doses of LSD (25µg, 50µg, 100µg, 200µg, and 200µg 1 hour post-ketanserin administration) on healthy participants. Sixteen subjects underwent assessments of subjective effects, physiological responses, plasma BDNF levels, and LSD plasma concentrations. The findings provide insights into LSD's mechanism of action. This research falls under the Tech category.